Hematopoietic Stem Cell Transplantation and Implications for Cell Therapy Reimbursement
| Autor: | Richard T. Maziarz, Dawn Driscoll |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
medicine.medical_specialty
United States Food and Drug Administration medicine.medical_treatment Cell Cell- and Tissue-Based Therapy Hematopoietic Stem Cell Transplantation Cell Biology Hematopoietic stem cell transplantation Biology Centers for Medicare and Medicaid Services U.S United States Cell therapy medicine.anatomical_structure Immunology Genetics medicine Molecular Medicine Humans Stem cell Intensive care medicine Reimbursement health care economics and organizations |
| Zdroj: | Cell Stem Cell. (6):609-612 |
| ISSN: | 1934-5909 |
| DOI: | 10.1016/j.stem.2011.05.013 |
| Popis: | As costly stem cell treatments progress from experimental concepts toward licensed products and routine procedures, governmental and private payers grapple with shrinking budgets to cover more lives. We describe efforts underway in the US to create mechanisms for reimbursement of cell therapies and discuss other reimbursement-related issues for the stem cell community. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|